Scientists at Precision for Medicine (formerly ApoCell) have developed innovative assays to support pre-clinical and clinical drug development. Our meticulous approach for biomarker quantification has led to the discovery of markers that correlate with clinical response to both conventional and molecular targeted therapies. These specific case studies highlight technology milestones and examples of applications using our proprietary process.